Always being attracted to publications around anything to do with melanoma skin cancer, having experienced family tragedies that drive my interest and research, this newsletter from the Skin Cancer Foundation really caught my eye.

It seems there is more of a push than ever before to drive the message home and it's actually not all unhappy news. Besides the complex statistics to take on board, there are also many hopeful messages.

Some of the pertinent aspects for me in this report are described below.

Search more than 200 pages on this site...

Melanoma strikes people increasingly younger 

Melanoma in children

This type of cancer is:

  • The most common form of cancer for young adults 25-29 years old
  • The second most common form of cancer for young people 15-25 years old
  • Attacking teen tanners as the fastest-growing group of skin cancer victims

The real life dramas of three young women diagnosed with melanoma in their early 20s is also told.

Melanoma Male statistics

melanoma-on-foreheadMelanoma on forehead

More details described:

  • Half all melanoma skin cancers are in men over 50
  • Male deaths are increasing from the disease, whereas women have decreased  
  • Men are less likely to have skin checkups done than women
  • Men are less likely to protect their skin from the sun's UV rays potential damage
  • By comparison, men are outdoors far more than women - in work as well as play

Some good Melanoma stories

There are many encouraging stories told about people recovering from melanoma skin cancer. 

melanoma-molesTypical Melanoma amongst moles

One such story is told about a young man who is only 26 years old. Diagnosed at 25, he considers himself extremely lucky in that he had brushed off the fact that he had a mole on his head that needed checking out.

He thought it wasn't anything to worry about, as he wasn't likely to have anything like cancer at his age plus there was no family history of cancer. Like I am sure many people do!

Well, he now advocates, as well as practices, prevention habits that include: 

  • wearing sunscreen every day that he is outdoors
  • wearing protective clothing
  • checking his body regularly for any signs of suspicious growths

New alternative therapies for Melanoma

Always keen on 'alternative' as opposed to mainstream, I was encouraged to find the FDA have approved 2 new therapies for Metastatic (spreading) Melanomas:

  1. Ipilumumab (Yervoy) focuses on the activation of 'pre-existing immune cells capable of recognizing and attacking cancer cells'.
    Although this activation is done artificially through the creation of antibodies, (previously impossible to do), the concept of alerting these antibodies into doing their job appeals to me enormously.
    There is a wonderful story of a man who has beaten the disease through this treatment that will encourage many people to try it! However, as with all things artificial, like the dreaded Chemotherapy, it seems there are toxic side effects to contend with.
    They refer to this as "autoimmune toxicity" and up to 60% will experience this, generally through the "skin, large intestine, endocrine glands and liver".
    Only 25% of these symptoms become severe and will require further treatment via corticosteroids, without which some of these side effects can actually become life threatening.

  2. Vemurafenib (Zelboraf) is the "first molecularly targeted therapy for melanoma".
    It targets a key enzyme called BRAF, which is known to mutate in approximately 50% of all melanoma cases, thereby escaping the body's natural immune system.
    Medication is in pill form twice daily, with a 90% regression success over anything from 6 to 18 months. In some fortunate cases even complete disappearance of any sign of melanoma.
    The down side is that the cancer seems to then start growing again as the body grows immune to the treatment.
    Doctors then predominately change to another form of treatment.
    Toxicities seem inevitable and range from skin rashes, increased sun sensitivity and even squamous cell carcinomas, to joint swelling and fatigue.

However, these "alternative therapies" are not the only kind I look for. I often prefer the more natural, holistic approach and the following are some sites I enjoy:

  • My favorite is a UK based site called Cancer Active 
  • Yes to Life is another Uk based site promoting a creative and positive attitude towards cancer.
  • A US based site that seems to encourage similar thinking and has great support available. 

Here is an interesting video that tells a story...

Understanding the stages of melanoma

The following stages helped me to understand why it's important to have anything suspicious checked out:

  • In Situ: The cancer is superficial and has not invaded the skin
  • Stage One: It has not invaded the skin and is less than 1mm thick
  • Stage Two: It has yet to spread but is at least 1mm thick
  • Stage Three: It has spread from the original site, to either the local lymph nodes or the skin between the primary tumor and nearby lymph nodes.
  • Stage Four: It has spread to distant lymph nodes, limbs or internal organs

NB:Anything In Situ or Stage One has a greater than 80% chance of survival 5 years after prognosis.

Melanoma statistics different in Europe?

Some facts that surprised me about the status of melanoma cancers in Europe include:

  • 21,000 people die from the disease every year in Europe
  • This is more than double those in the USA and almost half ALL related deaths worldwide
  • Europe traditionally has not had a solid education program about Skin Cancer or Melanoma specifically

Understandably the Skin Cancer Foundation has taken these stats on board and encouraged new organizations to start up relatively recently to share their information about skin cancer awareness. Key ones are:

  • Euromelanoma - a pan-European skin cancer awareness program
  • Epiderm and Eurosun - research companies
  • The European Partnership for Action against Cancer
  • The Romanian Skin Cancer Foundation

New! Comments

Have your say... please leave me a comment in the box below.